Paul S Giacomini (P S Giacomini)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Topics

Disease Activity

Multiple Sclerosis

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

This page only lists publications with an associated author ORCID identifier.

Publications

Jiwon Oh, Virender Bhan, Anthony L Traboulsee, Sarah A Morrow, Liesly Lee, Michael Levin, Courtney S Casserly, Mark S Freedman, Paul S Giacomini, François Émond, Penelope Smyth, Fraser Clift, Daniel Selchen
Health Canada drug approval process: a barrier to personalized care in multiple sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
Jiwon Oh, Virender Bhan, Anthony L Traboulsee, Sarah A Morrow, Liesly Lee, Michael Levin, Courtney S Casserly, Mark S Freedman, Paul S Giacomini, François Émond, Penelope Smyth, Fraser Clift, Daniel Selchen
Health Canada Drug Approval Process: A Barrier to Personalized Care in Multiple Sclerosis. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Paul S Giacomini, Jiwon Oh, Sarah A Morrow, Philippe Beauchemin, Fraser Clift, Virginia Devonshire, Penelope Smyth
Virtual management of multiple sclerosis: providing access or just phoning it in? The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2023)
Koji Shinoda, Rui Li, Ayman Rezk, Ina Mexhitaj, Kristina R Patterson, Mihir Kakara, Leah Zuroff, Jeffrey L Bennett, H-Christian von Büdingen, Robert Carruthers, Keith R Edwards, Robert Fallis, Paul S Giacomini, Benjamin M Greenberg, David A Hafler, Carolina Ionete, Ulrike W Kaunzner, Christopher B Lock, Erin E Longbrake, Gabriel Pardo, Fredrik Piehl, Martin S Weber, Tjalf Ziemssen, Dina Jacobs, Jeffrey M Gelfand, Anne H Cross, Briana Cameron, Bruno Musch, Ryan C Winger, Xiaoming Jia, Christopher T Harp, Ann Herman, Amit Bar-Or
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America 120 (3) (2023)
Ian J Tagge, Ilana R Leppert, Dumitru Fetco, Jennifer Sw Campbell, David A Rudko, Robert A Brown, Nikola Stikov, G Bruce Pike, Paul S Giacomini, Douglas Lorne Arnold, Sridar Narayanan
Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (13) (2022)
Stephen L Hauser, Anne H Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G Meuth, Paul S Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A Häring, Valentine Jehl, Bernd C Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (10) (2022)
Thomas Berger, B Brochet, L Brambilla, Paul S Giacomini, X Montalbán, A Vasco Salgado, R Su, A Bretagne
Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing-remitting multiple sclerosis in a real-world clinical setting: PROTEC. Multiple sclerosis journal - experimental, translational and clinical 5 (4) (2019)
Paul S Giacomini
Rebound disease in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 24 (8) (2018)
Rui Li, Ayman Rezk, Mathab Ghadiri, Felix Luessi, Frauke Zipp, Hulun Li, Paul S Giacomini, Jack Antel, Amit Bar-Or
Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis. Journal of immunology (Baltimore, Md. : 1950) 198 (2) (2016)